Abstract: An orally administered dosage form that facilitates delivery of an agent locally in the buccal cavity for a sustained period of time includes mucoadhesive particles that are made of at least a mucoadhesive material combined with the agent, and which are dispersed in a disintegrating film. The dosage form is capable of delivering an agent to a patient at the desired oral mucosa site over an extended period of time while reducing patient discomfort or annoyance associated with conventional sustained release mucoadhesive films that must reside on the oral mucosa during the period of sustained release.

Abstract: Disclosed is a description and methods for formulating oral films containing lipophilic active ingredient(s), more particularly lipophilic active having a positive logP. The method involves dispersing the lipophilic active(s) in a carrier oil and uniformly distributing them as emulsified oil droplets into a polymer matrix. The methods reported here produce oral films containing a stable emulsion with up to 40% oil phase. The oil phase consists of the carrier oil and lipophilic active(s). This offers the possibility to enhance the amount of lipophilic actives to be included in the film formulation while preserving the film characteristics. The resulting oral films offer a standardized dosage form for lipophilic actives as well as easier and more convenient administration, transportation, handling, and storage.

Abstract: Disclosed is a description and methods for formulating oral films containing lipophilic active ingredient(s), more particularly lipophilic active having a positive log P. The method involves dispersing the lipophilic active(s) in a carrier oil and uniformly distributing them as emulsified oil droplets into a polymer matrix. The methods reported here produce oral films containing a stable emulsion with up to 40% oil phase. The oil phase consists of the carrier oil and lipophilic active(s). This offers the possibility to enhance the amount of lipophilic actives to be included in the film formulation while preserving the film characteristics. The resulting oral films offer a standardized dosage form for lipophilic actives as well as easier and more convenient administration, transportation, handling, and storage.

Abstract: Disclosed is a description and methods for formulating oral films containing lipophilic active ingredient(s), more particularly lipophilic active having a positive log P. The method involves dispersing the lipophilic active(s) in a carrier oil and uniformly distributing them as emulsified oil droplets into a polymer matrix. The methods reported here produce oral films containing a stable emulsion with up to 40% oil phase. The oil phase consists of the carrier oil and lipophilic active(s). This offers the possibility to enhance the amount of lipophilic actives to be included in the film formulation while preserving the film characteristics. The resulting oral films offer a standardized dosage form for lipophilic actives as well as easier and more convenient administration, transportation, handling, and storage.

Abstract: An orally administered dosage form that facilitates delivery of an agent locally in the buccal cavity for a sustained period of time includes mucoadhesive particles that are made of at least a mucoadhesive material combined with the agent, and which are dispersed in a disintegrating film. The dosage form is capable of delivering an agent to a patient at the desired oral mucosa site over an extended period of time while reducing patient discomfort or annoyance associated with conventional sustained release mucoadhesive films that must reside on the oral mucosa during the period of sustained release.

Abstract: An orally administered dosage form that facilitates delivery of an agent locally in the buccal cavity for a sustained period of time includes mucoadhesive particles that are made of at least a mucoadhesive material combined with the agent, and which are dispersed in a disintegrating film. The dosage form is capable of delivering an agent to a patient at the desired oral mucosa site over an extended period of time while reducing patient discomfort or annoyance associated with conventional sustained release mucoadhesive films that must reside on the oral mucosa during the period of sustained release.

Abstract: Disclosed is a description and methods for formulating oral films containing lipophilic active ingredient(s), more particularly lipophilic active having a positive log P. The method involves dispersing the lipophilic active(s) in a carrier oil and uniformly distributing them as emulsified oil droplets into a polymer matrix. The methods reported here produce oral films containing a stable emulsion with up to 40% oil phase. The oil phase consists of the carrier oil and lipophilic active(s). This offers the possibility to enhance the amount of lipophilic actives to be included in the film formulation while preserving the film characteristics. The resulting oral films offer a standardized dosage form for lipophilic actives as well as easier and more convenient administration, transportation, handling, and storage.

Abstract: A humidity sensor having a housing, a data logger that has such a humidity sensor as well as a evaluation method for the humidity sensor or the data logger. The housing of the humidity sensor has a recess in which a humidity sensor element is situated. To protect the humidity sensor element against the ingress of water, a membrane is provided that covers at least a portion of the recess and thus defines a detection volume around the humidity sensor element. This membrane allows for an exchange of air with the surroundings so that the humidity sensor element is able to detect the air humidity. It is also designed in such a way that it prevents the ingress of water. The detection volume is designed to be as small so that the humidity of the detection volume adapts quickly to the surrounding climate that is to be measured.

Abstract: An electrical distribution center, bussed electrical center, or power distribution box includes a housing containing a plurality of electronic devices including a plurality of removable electronic devices. The housing further defines a plurality of openings on opposite side of the housing so that the removable electronic devices are accessible through at least one of the openings. The housing receivably couples at least one wire cable that is in electrical communication with the removable electronic devices. When the wire cable is coupled to the housing, the removable electronic device is accessed through one of the openings while the coupled wire cable remains attached to the housing. A relay and fuse electronic circuit arrangement and a fuse electronic circuit arrangement each effectively utilize the allotted packaging space within the housing while also conserving the use of circuit board traces.

Abstract: An electrical current-carrying apparatus includes a housing containing a plurality of electronic devices that also includes a plurality of removable electronic devices. The housing further defines a plurality of openings so that the removable devices are accessible through at least one of the plurality of openings. The housing receivably couples at least one wire cable that is in electrical communication with the electronic devices. When the at least one wire cable is receivably coupled to the housing and the at least one removable device needs accessed, the at least one removable electronic device is accessed through at least one of the plurality of openings while the at least one coupled wire cable remains attached to the housing. A relay and fuse electronic circuit arrangement and a fuse electronic circuit arrangement each effectively utilize the allotted packaging space within the apparatus while also conserving the use of circuit board trace.

Abstract: A method of providing a shared application infrastructure simultaneously to multiple independent virtual private networks with potentially overlapping IP addresses, involves connecting to an underlying layer 1, 2 or 3 virtual private network offering one or more virtual private networks, determining which virtual private network traffic is being received from or sent into, maintaining logically separate routing tables per VPN to allow overlapping addresses, and providing an application which provides a logical instance of the service to each VPN.

Abstract: A method of providing a shared application infrastructure simultaneously to multiple independent virtual private networks with potentially overlapping IP addresses, involves connecting to an underlying layer 1, 2 or 3 virtual private network offering one or more virtual private networks, determining which virtual private network traffic is being received from or sent into, maintaining logically separate routing tables per VPN to allow overlapping addresses, and providing an application which provides a logical instance of the service to each VPN.